Cargando…
Diabetic Retinopathy and Microalbuminuria Can Predict Macroalbuminuria and Renal Function Decline in Japanese Type 2 Diabetic Patients: Japan Diabetes Complications Study
OBJECTIVE: To examine the interactive relationship between diabetic retinopathy (DR) and diabetic nephropathy (DN) in type 2 diabetic patients and to elucidate the role of DR and microalbuminuria on the onset of macroalbuminuria and renal function decline. RESEARCH DESIGN AND METHODS: We explored th...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747927/ https://www.ncbi.nlm.nih.gov/pubmed/23620478 http://dx.doi.org/10.2337/dc12-2327 |
_version_ | 1782281005928808448 |
---|---|
author | Moriya, Tatsumi Tanaka, Shiro Kawasaki, Ryo Ohashi, Yasuo Akanuma, Yasuo Yamada, Nobuhiro Sone, Hirohito Yamashita, Hidetoshi Katayama, Shigehiro |
author_facet | Moriya, Tatsumi Tanaka, Shiro Kawasaki, Ryo Ohashi, Yasuo Akanuma, Yasuo Yamada, Nobuhiro Sone, Hirohito Yamashita, Hidetoshi Katayama, Shigehiro |
author_sort | Moriya, Tatsumi |
collection | PubMed |
description | OBJECTIVE: To examine the interactive relationship between diabetic retinopathy (DR) and diabetic nephropathy (DN) in type 2 diabetic patients and to elucidate the role of DR and microalbuminuria on the onset of macroalbuminuria and renal function decline. RESEARCH DESIGN AND METHODS: We explored the effects of DR and microalbuminuria on the progression of DN from normoalbuminuria and low microalbuminuria (<150 mg/gCr) to macroalbuminuria or renal function decline in the Japan Diabetes Complications Study (JDCS), which is a nationwide randomized controlled study of type 2 diabetic patients focusing on lifestyle modification. Patients were divided into four groups according to presence or absence of DR and MA: normoalbuminuria without DR [NA(DR−)] (n = 773), normoalbuminuria with DR [NA(DR+)] (n = 279), microalbuminuria without DR [MA(DR−)] (n = 277), and microalbuminuria with DR [MA(DR+)] (n = 146). Basal urinary albumin-to-creatinine ratio and DR status were determined at baseline and followed for a median of 8.0 years. RESULTS: Annual incidence rates of macroalbuminuria were 1.6/1,000 person-years (9 incidences), 3.9/1,000 person-years (8 incidences), 18.4/1,000 person-years (34 incidences), and 22.1/1,000 person-years (22 incidences) in the four groups, respectively. Multivariate-adjusted hazard ratios of the progression to macroalbuminuria were 2.48 (95% CI 0.94–6.50; P = 0.07), 10.40 (4.91–22.03; P < 0.01), and 11.55 (5.24–25.45; P < 0.01) in NA(DR+), MA(DR−), and MA(DR+), respectively, in comparison with NA(DR−). Decline in estimated glomerular filtration rate (GFR) per year was two to three times faster in MA(DR+) (−1.92 mL/min/1.73 m(2)/year) than in the other groups. CONCLUSIONS: In normo- and low microalbuminuric Japanese type 2 diabetic patients, presence of microalbuminuria at baseline was associated with higher risk of macroalbuminuria in 8 years. Patients with microalbuminuria and DR showed the fastest GFR decline. Albuminuria and DR should be considered as risk factors of renal prognosis in type 2 diabetic patients. An open sharing of information will benefit both ophthalmologists and diabetologists. |
format | Online Article Text |
id | pubmed-3747927 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | American Diabetes Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-37479272014-09-01 Diabetic Retinopathy and Microalbuminuria Can Predict Macroalbuminuria and Renal Function Decline in Japanese Type 2 Diabetic Patients: Japan Diabetes Complications Study Moriya, Tatsumi Tanaka, Shiro Kawasaki, Ryo Ohashi, Yasuo Akanuma, Yasuo Yamada, Nobuhiro Sone, Hirohito Yamashita, Hidetoshi Katayama, Shigehiro Diabetes Care Original Research OBJECTIVE: To examine the interactive relationship between diabetic retinopathy (DR) and diabetic nephropathy (DN) in type 2 diabetic patients and to elucidate the role of DR and microalbuminuria on the onset of macroalbuminuria and renal function decline. RESEARCH DESIGN AND METHODS: We explored the effects of DR and microalbuminuria on the progression of DN from normoalbuminuria and low microalbuminuria (<150 mg/gCr) to macroalbuminuria or renal function decline in the Japan Diabetes Complications Study (JDCS), which is a nationwide randomized controlled study of type 2 diabetic patients focusing on lifestyle modification. Patients were divided into four groups according to presence or absence of DR and MA: normoalbuminuria without DR [NA(DR−)] (n = 773), normoalbuminuria with DR [NA(DR+)] (n = 279), microalbuminuria without DR [MA(DR−)] (n = 277), and microalbuminuria with DR [MA(DR+)] (n = 146). Basal urinary albumin-to-creatinine ratio and DR status were determined at baseline and followed for a median of 8.0 years. RESULTS: Annual incidence rates of macroalbuminuria were 1.6/1,000 person-years (9 incidences), 3.9/1,000 person-years (8 incidences), 18.4/1,000 person-years (34 incidences), and 22.1/1,000 person-years (22 incidences) in the four groups, respectively. Multivariate-adjusted hazard ratios of the progression to macroalbuminuria were 2.48 (95% CI 0.94–6.50; P = 0.07), 10.40 (4.91–22.03; P < 0.01), and 11.55 (5.24–25.45; P < 0.01) in NA(DR+), MA(DR−), and MA(DR+), respectively, in comparison with NA(DR−). Decline in estimated glomerular filtration rate (GFR) per year was two to three times faster in MA(DR+) (−1.92 mL/min/1.73 m(2)/year) than in the other groups. CONCLUSIONS: In normo- and low microalbuminuric Japanese type 2 diabetic patients, presence of microalbuminuria at baseline was associated with higher risk of macroalbuminuria in 8 years. Patients with microalbuminuria and DR showed the fastest GFR decline. Albuminuria and DR should be considered as risk factors of renal prognosis in type 2 diabetic patients. An open sharing of information will benefit both ophthalmologists and diabetologists. American Diabetes Association 2013-09 2013-08-13 /pmc/articles/PMC3747927/ /pubmed/23620478 http://dx.doi.org/10.2337/dc12-2327 Text en © 2013 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details. |
spellingShingle | Original Research Moriya, Tatsumi Tanaka, Shiro Kawasaki, Ryo Ohashi, Yasuo Akanuma, Yasuo Yamada, Nobuhiro Sone, Hirohito Yamashita, Hidetoshi Katayama, Shigehiro Diabetic Retinopathy and Microalbuminuria Can Predict Macroalbuminuria and Renal Function Decline in Japanese Type 2 Diabetic Patients: Japan Diabetes Complications Study |
title | Diabetic Retinopathy and Microalbuminuria Can Predict Macroalbuminuria and Renal Function Decline in Japanese Type 2 Diabetic Patients: Japan Diabetes Complications Study |
title_full | Diabetic Retinopathy and Microalbuminuria Can Predict Macroalbuminuria and Renal Function Decline in Japanese Type 2 Diabetic Patients: Japan Diabetes Complications Study |
title_fullStr | Diabetic Retinopathy and Microalbuminuria Can Predict Macroalbuminuria and Renal Function Decline in Japanese Type 2 Diabetic Patients: Japan Diabetes Complications Study |
title_full_unstemmed | Diabetic Retinopathy and Microalbuminuria Can Predict Macroalbuminuria and Renal Function Decline in Japanese Type 2 Diabetic Patients: Japan Diabetes Complications Study |
title_short | Diabetic Retinopathy and Microalbuminuria Can Predict Macroalbuminuria and Renal Function Decline in Japanese Type 2 Diabetic Patients: Japan Diabetes Complications Study |
title_sort | diabetic retinopathy and microalbuminuria can predict macroalbuminuria and renal function decline in japanese type 2 diabetic patients: japan diabetes complications study |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747927/ https://www.ncbi.nlm.nih.gov/pubmed/23620478 http://dx.doi.org/10.2337/dc12-2327 |
work_keys_str_mv | AT moriyatatsumi diabeticretinopathyandmicroalbuminuriacanpredictmacroalbuminuriaandrenalfunctiondeclineinjapanesetype2diabeticpatientsjapandiabetescomplicationsstudy AT tanakashiro diabeticretinopathyandmicroalbuminuriacanpredictmacroalbuminuriaandrenalfunctiondeclineinjapanesetype2diabeticpatientsjapandiabetescomplicationsstudy AT kawasakiryo diabeticretinopathyandmicroalbuminuriacanpredictmacroalbuminuriaandrenalfunctiondeclineinjapanesetype2diabeticpatientsjapandiabetescomplicationsstudy AT ohashiyasuo diabeticretinopathyandmicroalbuminuriacanpredictmacroalbuminuriaandrenalfunctiondeclineinjapanesetype2diabeticpatientsjapandiabetescomplicationsstudy AT akanumayasuo diabeticretinopathyandmicroalbuminuriacanpredictmacroalbuminuriaandrenalfunctiondeclineinjapanesetype2diabeticpatientsjapandiabetescomplicationsstudy AT yamadanobuhiro diabeticretinopathyandmicroalbuminuriacanpredictmacroalbuminuriaandrenalfunctiondeclineinjapanesetype2diabeticpatientsjapandiabetescomplicationsstudy AT sonehirohito diabeticretinopathyandmicroalbuminuriacanpredictmacroalbuminuriaandrenalfunctiondeclineinjapanesetype2diabeticpatientsjapandiabetescomplicationsstudy AT yamashitahidetoshi diabeticretinopathyandmicroalbuminuriacanpredictmacroalbuminuriaandrenalfunctiondeclineinjapanesetype2diabeticpatientsjapandiabetescomplicationsstudy AT katayamashigehiro diabeticretinopathyandmicroalbuminuriacanpredictmacroalbuminuriaandrenalfunctiondeclineinjapanesetype2diabeticpatientsjapandiabetescomplicationsstudy AT diabeticretinopathyandmicroalbuminuriacanpredictmacroalbuminuriaandrenalfunctiondeclineinjapanesetype2diabeticpatientsjapandiabetescomplicationsstudy |